Intravenous immune globulin (IVIG) shortage affects large commercial and independent specialty pharmacies across the country

Intravenous immune globulin (IVIG) shortage affects large commercial and independent specialty pharmacies across the country As an independently owned specialty pharmacy, OptionOne collaborates with pharma manufacturers, distribution centers and medical providers to address the widespread intravenous immune globulin (IVIG) shortage. These national shortages significantly impact patients across the country, including right here in Oklahoma. Patients…

Details

OptionOne Pharmacy Awarded Oklahoma Top Workplaces 2018

THE OKLAHOMAN NAMES OPTIONONE PHARMACY A WINNER OF THE OKLAHOMA TOP WORKPLACES 2018 AWARD Oklahoma City, OK – December 9, 2018 – OptionOne Pharmacy has been awarded a 2018 Top Workplaces honor by The Oklahoman. The list is based solely on employee feedback gathered through a third-party survey administered by research partner Energage, LLC (formerly WorkplaceDynamics),…

Details

OptionOne recognized as one of central Oklahoma’s fastest growing private companies.

Greater Oklahoma City Chamber and sponsors recognized OptionOne Pharmacy for the fourth year in a row as one of Central Oklahoma’s fastest growing private companies at the Metro 50 Awards on Monday, September 24, 2018. According to the Greater Oklahoma City Chamber website, “the Metro 50 Award allows both emerging companies, as well as companies…

Details

OptionOne Pharmacy Partners with Citus Health Digital Technology Solutions

OptionOne Pharmacy partners with Citus Health for innovative digital technology to optimize workflows, streamline communication and documentation, and reduce operational costs that will improve patient and referral partner relationships. OKLAHOMA CITY, OK – JULY 25, 2018 OptionOne Pharmacy today announces that we have chosen Citus Health, a digital health solutions provider for the post-acute care industry,…

Details

Congress Passes Medicare Part B Transitional Reimbursement Legislation

Early this morning, Congress passed legislation to allow transitional reimbursement for the clinical services that are integral to home infusion therapy under Medicare Part B. Providers of home and specialty infusion therapy and the Medicare beneficiaries they serve have been advocating for this much-needed remedy for the past year. This action by Congress addresses a severe gap…

Details